Last reviewed · How we verify

dose-escalated selinexor treatment

Sheba Medical Center · Phase 1 active Small molecule

dose-escalated selinexor treatment is a Small molecule drug developed by Sheba Medical Center. It is currently in Phase 1 development. Also known as: KPT-330.

At a glance

Generic namedose-escalated selinexor treatment
Also known asKPT-330
SponsorSheba Medical Center
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about dose-escalated selinexor treatment

What is dose-escalated selinexor treatment?

dose-escalated selinexor treatment is a Small molecule drug developed by Sheba Medical Center.

Who makes dose-escalated selinexor treatment?

dose-escalated selinexor treatment is developed by Sheba Medical Center (see full Sheba Medical Center pipeline at /company/sheba-medical-center).

Is dose-escalated selinexor treatment also known as anything else?

dose-escalated selinexor treatment is also known as KPT-330.

What development phase is dose-escalated selinexor treatment in?

dose-escalated selinexor treatment is in Phase 1.

Related